<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>2023</volume><submitter>Pinho-Jr JDS</submitter><pubmed_abstract>&lt;h4>Background&lt;/h4>Overweight and obesity are global health issues, impacting a significant portion of young adults. Obesity is a complex condition influenced by genetics and environmental factors, leading to increased susceptibility to cardiovascular diseases (CVDs), hypertension, dyslipidemia, and insulin resistance. Irisin, a protein derived from the cleavage of fibronectin type III domain-containing protein 5, may have relationship with these cardiometabolic diseases.&lt;h4>Objective&lt;/h4>This systematic review aims to examine the relationship between serum irisin levels and obesity, particularly in individuals predisposed to cardiovascular risk factors.&lt;h4>Methods&lt;/h4>A thorough literature search was conducted in multiple databases, including "Science Direct," "Scopus," "PubMed," and "Lil</pubmed_abstract><journal>International journal of inflammation</journal><pagination>5810157</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10602702</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Irisin and Cardiometabolic Disorders in Obesity: A Systematic Review.</pubmed_title><pmcid>PMC10602702</pmcid><pubmed_authors>Cavararo CDS</pubmed_authors><pubmed_authors>Medeiros RF</pubmed_authors><pubmed_authors>Barroso SG</pubmed_authors><pubmed_authors>Pinho-Jr JDS</pubmed_authors><pubmed_authors>de Matos AC</pubmed_authors><pubmed_authors>Camacho FA</pubmed_authors><pubmed_authors>Baiao PF</pubmed_authors></additional><is_claimable>false</is_claimable><name>Irisin and Cardiometabolic Disorders in Obesity: A Systematic Review.</name><description>&lt;h4>Background&lt;/h4>Overweight and obesity are global health issues, impacting a significant portion of young adults. Obesity is a complex condition influenced by genetics and environmental factors, leading to increased susceptibility to cardiovascular diseases (CVDs), hypertension, dyslipidemia, and insulin resistance. Irisin, a protein derived from the cleavage of fibronectin type III domain-containing protein 5, may have relationship with these cardiometabolic diseases.&lt;h4>Objective&lt;/h4>This systematic review aims to examine the relationship between serum irisin levels and obesity, particularly in individuals predisposed to cardiovascular risk factors.&lt;h4>Methods&lt;/h4>A thorough literature search was conducted in multiple databases, including "Science Direct," "Scopus," "PubMed," and "Lil</description><dates><release>2023-01-01T00:00:00Z</release><publication>2023</publication><modification>2025-04-05T11:54:13.171Z</modification><creation>2025-04-05T11:54:13.171Z</creation></dates><accession>S-EPMC10602702</accession><cross_references><pubmed>37900979</pubmed><doi>10.1155/2023/5810157</doi></cross_references></HashMap>